Company news

На странице:
Avifavir is the first direct-acting antiviral drug registered in Russia that has proven effective against COVID-19 in ...
01.06.2020
Median elimination of the virus in four days compared to nine days with standard therapy, according to the study ...
22.05.2020
Moscow, May 13, 2020 - The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and the ChemRar Group ...
14.05.2020
Russia is set to test the antiviral drug Favipiravir as a treatment for COVID-19 following "excellent results" in ...
07.04.2020
The drug has been used successfully in China to cure coronavirus patients Moscow, March 26, 2020 – The Supervisory ...
26.03.2020
Avineuro Project from ChemRar Research Institute has finished the multicenter, randomized, double-blind, ...
27.11.2019
BIOTECHMED 2019 Forum that involved representatives of ChemRar Group and international accelerator biobridge-2019, ...
27.11.2019
The international accelerator biobridge-2019 has established a special nomination for the finalists of the Startup ...
27.11.2019
On July 25, 2019, during the Selection Day at the Boiling Point ASI in Moscow, we will finally choose the strongest ...
27.11.2019
Russian Venture Company announced the start of selecting a managing company for a ₽4.5-billion fund founded jointly ...
27.11.2019
June 27 was the pre-selection day of biobridge 2019 that brought the first on-site event organized to introduce teams ...
27.11.2019
Today, on May 31, 2019, the finale of the open competition for development teams and start-ups, which create drug ...
27.11.2019